ClinicalTrials.gg
Sign In
Status unknownNCT01711151Updated Oct 22, 2012

Interstitial Lung Disease Questionnaire

An observational study in Interstitial Lung Disease, sponsored by University of East Anglia. Status unknown at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-10-22.

Sponsored by University of East Anglia · Observational

The sponsor has not verified this record recently (last verified Oct 2012), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
304
Ages
18 Years and older
Sex
All
01

Study summary

  1. To evaluate the health status of patients with Interstitial Lung Disease (ILD), and how this varies between subgroups of ILD.
  2. To investigate the prevalence of symptoms, anxiety, depression, and sleep-disordered breathing within ILD patient population.
  3. To assess the economic impact of ILD.
  4. To understand how self-aware ILD patients are regarding their treatment/management.
  5. To compare the demographic details, including smoking status and occupational history, of patients with interstitial lung disease
Read the detailed description

Primary endpoint

  • Health status in the target populations, as determined by the K-BILD questionnaire.

Secondary endpoints -

  • Severity of dyspnoea suffered by patients
  • Prevalence of anxiety and depression
  • Prevalence of sleep-disordered breathing symptoms
  • Degree of self-awareness displayed by patients
  • The costs associated with ILD from a patient and healthcare perspective.
  • Demographic details
02

Conditions studied

  • Interstitial Lung Disease

Keywords

  • ILD
03

In context

Lung Diseases, Interstitial

656 studies on the registry are indexed under Lung Diseases, Interstitial; 241 are open to participants now.

This study's planned enrollment of 304 is above the median of 150 across 273 observational studies indexed under Lung Diseases, Interstitial.

Browse Lung Diseases, Interstitial studies →

Lead sponsor

University of East Anglia is the lead sponsor of 79 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Secondary Care

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female
  • Age greater than 18 years of age
  • Any smoking status
  • Diagnosis of Interstitial Lung Disease as defined below
  • Full pulmonary lung function tests and routine immunological tests undertaken within 6 months of entry into study

Exclusion criteria

Exclusion Criteria:

  • Unable to give consent to take part
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
304 participants (estimated)

Groups and cohorts

  • Idiopathic Pulmonary Fibrosis

    Questionnaire evaluation

  • Non Idiopathic Pulmonary Fibrosis

    Questionnaire evaluation

  • Sarciodosis

    Questionnaire evaluation

  • Healthy Controls

    Questionnaire evaluation

06

What researchers measure

Primary outcomes

  1. Difference in the Mean K-BILD score between the 4 groups

    HRQL

    Time frame: Baseline

Secondary outcomes

  1. Severity of dyspnoea suffered by patients

    Time frame: Baseline

  2. Prevalence of anxiety and depression

    Time frame: Baseline

  3. Prevalence of sleep-disordered breathing symptoms

    Time frame: Baseline

  4. Degree of self-awareness displayed by patients

    Time frame: Baseline

  5. The costs associated with ILD from a patient and healthcare perspective

    Time frame: Baseline

  6. Demographic details

    Time frame: Baseline

07

Study locations

1 site
  • Norfolk and Norwich Univeristy Hospital NHS foundation Trust
    Norwich, Norfolk NR47UY, United Kingdom
    • Christopher Atkins · Sub investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 22, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01711151
Lead sponsor
University of East Anglia
Responsible party
Sponsor
First posted
Oct 22, 2012
Start date
Nov 2012
Primary completion
Nov 2013 (estimated)
Completion
Nov 2013 (estimated)
Last update
Oct 22, 2012

Study contacts

Andrew M Wilson, MRCP, MD
Contact
a.m.wilson@uea.ac.uk
00441603591257
Christopher Atkins, MBBS, MRCP
Contact
christopher.atkins@nnuh.nhs.uk
00441603286286
Andrew M Wilson
principal investigator · University of East Anglia

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Lung Diseases, Interstitial →

Other studies from this sponsor

University of East Anglia

Start the discussion